NC
ALDR

Nexthera Capital’s Alder Biopharmaceuticals ALDR Stock Holding History

Nexthera Capital’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-39,000
Closed -$974K – 43
2016
Q2 		$974K Buy
+39,000
New +$1.06M 0.84% 21
2016
Q1 		– Sell
-60,000
Closed -$1.98M – 51
2015
Q4 		$1.98M Buy
+60,000
New +$2.03M 2.81% 10

Other funds holding ALDR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nexthera Capital's ALDR Position: Q3 2016 in Review

Nexthera Capital sold out of Alder Biopharmaceuticals (ALDR) in Q3 2016, closing a stake of 39,000 shares — an estimated $974K sold.

Nexthera Capital first reported a position in ALDR in Q4 2015 and held it in 2 quarters. The position peaked at $1.98M in Q4 2015. 159 funds tracked by Wall St. Rank hold ALDR as of Q3 2016.

  • Nexthera Capital reported no remaining Alder Biopharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Nexthera Capital sold 39,000 Alder Biopharmaceuticals shares in Q3 2016, an estimated $974K.
  • Nexthera Capital first reported a position in Alder Biopharmaceuticals in Q4 2015 and held it in 2 quarters.
  • Nexthera Capital's Alder Biopharmaceuticals position peaked at $1.98M in Q4 2015.
  • 159 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2016.

Based on Nexthera Capital's 13F filing for Q3 2016, filed 14 Nov 2016.